Maternal SSRIs experience and risk of ASD in offspring: a review.

Pregnant women taking antidepressants belonging to the class of selective serotonin reuptake inhibitors (SSRIs) may be at risk of having babies with autism spectrum disorders.

​This study examined the correlation between maternal use of antidepressants in the class of selective serotonin reuptake inhibitors (SSRIs) and the risk of autism spectrum disorders (ASD) in their offspring. Researchers sifted through data extracted from 12 studies. 

Researchers discovered women who took selective serotonin reuptake inhibitors during pregnancy faced increased risk of having babies with autism spectrum disorders. Evidence from this study show that maternal exposure to selective serotonin reuptake inhibitors during pregnancy may elevate the likelihood of giving birth to offspring with autism.